Cargando…

How safe it is to treat pregnant FMF patients with Anakinra?

Detalles Bibliográficos
Autores principales:	Ozdogan, H, Ugurlu, S, Ergezen, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599842/ http://dx.doi.org/10.1186/1546-0096-13-S1-P124

Ejemplares similares

Anakinra treatment in patients with Familial Mediterranean Fever: a single-center experience
por: Ugurlu, S, et al.
Publicado: (2015)

Anakinra for secondary amyloidosis in an adolescent with FMF and Behcet Disease
por: Bilginer, Y, et al.
Publicado: (2008)

Quality of life changes with canakinumab therapy in adults with colchicine resistant FMF
por: Gul, A, et al.
Publicado: (2015)

The effect of Anakinra on Quality-of-Life in a family with colchicine-resistant FMF
por: van der Hilst, J, et al.
Publicado: (2015)

Is Familial Mediterranean Fever a clinical diagnosis? Results of a field survey
por: Ozdogan, H, et al.
Publicado: (2015)

PW01-012 – Canakinumab in patients with FMF
por: Ugurlu, S, et al.
Publicado: (2013)

How long is the diagnosis of Familial Mediterranean Fever (FMF) delayed in a region where FMF is common in Turkey?
por: Karaaslan, Y, et al.
Publicado: (2015)

PReS-FINAL-2328: Developing and validating the new severity score for FMF
por: Demirkaya, E, et al.
Publicado: (2013)

P01-031 – Anakinra for colchicine resistant FMF
por: Ben-Zvi, I, et al.
Publicado: (2013)

Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey
por: Turgay, S, et al.
Publicado: (2015)

Featuring the phenotype of the FMF prototype
por: Ben-Zvi, I, et al.
Publicado: (2015)

PW01-015 – Canakinumab in adults with colchicin resistant FMF
por: Gül, A, et al.
Publicado: (2013)

P01-015 – Effect of Cochicine on cholesterol in FMF and BS
por: Ugurlu, S, et al.
Publicado: (2013)

Validity and reliability of medication adherence scale in FMF
por: Fidanci, BE, et al.
Publicado: (2015)

Acute phase reactants in the follow-up of patients with FMF
por: Arıcı, ZS, et al.
Publicado: (2015)

Clinical and subclinical features and MEFV mutation distribution in of FMF patients’ siblings
por: Gunduz, Z, et al.
Publicado: (2015)

PReS-FINAL-2213: Validation of inadequate drug response and definition of colchicum resistance in FMF
por: Demirkaya, E, et al.
Publicado: (2013)

Anti-IL1 therapy in patients with refractory FMF living inGermany
por: Buhl, B, et al.
Publicado: (2015)

Coexistence of PFAPA syndrome and FMF in Armenian children
por: Mkrtchyan, N, et al.
Publicado: (2015)

PReS-FINAL-2220: Cochlear involvement in FMF
por: Keskindemirci, G, et al.
Publicado: (2013)

PReS-FINAL-2221: An earliest diagnosis of FMF
por: Keskindemirci, G, et al.
Publicado: (2013)

The familial Mediterranean fever (FMF) 50 score: does it work in a controlled clinical trial? Re-analysis of the trial of rilonacept for patients with colchicine resistant or intolerant FMF
por: Hashkes, P, et al.
Publicado: (2015)

Prevalence of Mediterranean fever gene mutations in clinically suspected FMF patients in Algeria
por: Ait-Idir, D, et al.
Publicado: (2015)

Recurrent poliserositis succesfully treated with IL-1 receptor antagonist Anakinra
por: Lovillo, MS Camacho, et al.
Publicado: (2011)

PReS-FINAL-2223: The relationship between FMF, BD and epilepsy
por: Sargsyan, H
Publicado: (2013)

PW02-011 - Favorable response to anakinra in aisle patients
por: Ozdogan, H, et al.
Publicado: (2013)

Early effects of Anakinra in corticosteroid naïve SOJIA patients
por: Wulffraat, NM, et al.
Publicado: (2008)

PReS-FINAL-2219: Evaluation of autonomic function in FMF
por: Aktay Ayaz, N, et al.
Publicado: (2013)

PReS-FINAL-2222: FMF presenting with the features of malignancy
por: Keskindemirci, G, et al.
Publicado: (2013)

A child with cPAN as only manifestation of FMF
por: Khloyan, Gayane, et al.
Publicado: (2014)

The patient experience of Colchicine Resistant-Familial Mediterranean Fever (cr-FMF)
por: Dandekar, P, et al.
Publicado: (2015)

Long-term follow-up of systemic onset juvenile idiopathic arthritis patients treated with Anakinra
por: Gattorno, Marco, et al.
Publicado: (2011)

Developing of a new scale for assessing the adherence to colchicine treatment in pediatric patients with FMF
por: Yesilkaya, S, et al.
Publicado: (2015)

Arterial stiffness as a model to dissect chronic inflammation in FMF
por: Kukuy, O, et al.
Publicado: (2015)

Profile of cytokines, growth factors and chemokines during attacks of FMF
por: Bilginer, Y, et al.
Publicado: (2008)

Familial Mediterranean Fever (FMF) before the age of one year
por: Delion, F, et al.
Publicado: (2008)

PReS-FINAL-2227: QT and JT dispersion in children with FMF
por: Fidanci, K, et al.
Publicado: (2013)

Validity and reliability of medication adherence scale in FMF (adult version)
por: Fidanci, Berna Eren, et al.
Publicado: (2014)

Differential response to anakinra and adalimumab in a patient with DADA2 syndrome
por: Toz, B, et al.
Publicado: (2015)

PReS-FINAL-2318: The structural and functional changes of biomembrains of FMF and HSP with children
por: Sargsyan, H, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_68p9fqop0kecetqv4pibrvdnpi